The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126816121 12681612 1 I 20160409 20160810 20160824 20160824 EXP FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-068536 BRISTOL MYERS SQUIBB 63.86 YR M Y 0.00000 20160824 CN FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126816121 12681612 1 PS GLUCOPHAGE METFORMIN HYDROCHLORIDE 1 Oral 1000 MG, TID Y 20357 1000 MG FILM-COATED TABLET TID
126816121 12681612 2 C ELIQUIS APIXABAN 1 Oral U 0
126816121 12681612 3 C SIMVASTATIN. SIMVASTATIN 1 Oral U 0
126816121 12681612 4 C EZETROL EZETIMIBE 1 Oral 1 DF, QD 0 1 DF TABLET QD
126816121 12681612 5 C LYRICA PREGABALIN 1 Oral 2 DF, QD 0 2 DF CAPSULE QD
126816121 12681612 6 C KARDEGIC ASPIRIN LYSINE 1 Oral 1 DF, QD 0 1 DF POWDER FOR ORAL SUSPENSION QD
126816121 12681612 7 C LEXOMIL BROMAZEPAM 1 Oral 1 DF, QD 0 1 DF TABLET QD
126816121 12681612 8 C INEXIUM /01479302/ ESOMEPRAZOLE MAGNESIUM 1 Oral 1 DF, QD 0 1 DF GASTRO-RESISTANT CAPSULE QD
126816121 12681612 9 C LEVOTHYROX LEVOTHYROXINE 1 Oral 1 DF, QD 0 1 DF TABLET QD
126816121 12681612 10 C ZYLORIC ALLOPURINOL 1 Oral 1 DF, QD 0 1 DF TABLET QD
126816121 12681612 11 C VIMPAT LACOSAMIDE 1 Oral 1 DF, QD 0 1 DF FILM-COATED TABLET QD
126816121 12681612 12 C NOCTAMIDE LORMETAZEPAM 1 Oral 1 DF, QD 0 1 DF TABLET QD
126816121 12681612 13 C COMBODART DUTASTERIDETAMSULOSIN 1 Oral UNK 0 CAPSULE

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126816121 12681612 1 Diabetes mellitus
126816121 12681612 2 Product used for unknown indication
126816121 12681612 3 Product used for unknown indication
126816121 12681612 4 Product used for unknown indication
126816121 12681612 5 Product used for unknown indication
126816121 12681612 6 Product used for unknown indication
126816121 12681612 7 Product used for unknown indication
126816121 12681612 8 Product used for unknown indication
126816121 12681612 9 Product used for unknown indication
126816121 12681612 10 Product used for unknown indication
126816121 12681612 11 Product used for unknown indication
126816121 12681612 12 Product used for unknown indication
126816121 12681612 13 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
126816121 12681612 HO
126816121 12681612 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126816121 12681612 Acute kidney injury
126816121 12681612 Coma
126816121 12681612 Dialysis
126816121 12681612 Hyperkalaemia
126816121 12681612 Hypoglycaemia
126816121 12681612 Lactic acidosis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126816121 12681612 1 201604 20160410 0
126816121 12681612 5 20160412 0